nodes	percent_of_prediction	percent_of_DWPC	metapath
Enalapril—ACE—polycystic ovary syndrome	0.831	1	CbGaD
Enalapril—ACE—tunica intima—polycystic ovary syndrome	0.0157	0.249	CbGeAlD
Enalapril—SLC22A8—urine—polycystic ovary syndrome	0.00776	0.123	CbGeAlD
Enalapril—ACE—urine—polycystic ovary syndrome	0.00774	0.122	CbGeAlD
Enalapril—CYP3A4—urine—polycystic ovary syndrome	0.00385	0.0608	CbGeAlD
Enalapril—Toothache—Metformin—polycystic ovary syndrome	0.00361	0.0634	CcSEcCtD
Enalapril—Rhinorrhoea—Metformin—polycystic ovary syndrome	0.00271	0.0476	CcSEcCtD
Enalapril—SLC15A1—endometrium—polycystic ovary syndrome	0.00255	0.0404	CbGeAlD
Enalapril—Contusion—Metformin—polycystic ovary syndrome	0.00252	0.0442	CcSEcCtD
Enalapril—ACE—embryo—polycystic ovary syndrome	0.0025	0.0395	CbGeAlD
Enalapril—SLC22A7—endocrine gland—polycystic ovary syndrome	0.00223	0.0352	CbGeAlD
Enalapril—SLC15A1—vagina—polycystic ovary syndrome	0.00191	0.0302	CbGeAlD
Enalapril—ACE—endometrium—polycystic ovary syndrome	0.00183	0.0289	CbGeAlD
Enalapril—SLC15A1—endocrine gland—polycystic ovary syndrome	0.00179	0.0283	CbGeAlD
Enalapril—Nasal congestion—Metformin—polycystic ovary syndrome	0.00175	0.0307	CcSEcCtD
Enalapril—ACE—pituitary gland—polycystic ovary syndrome	0.00166	0.0262	CbGeAlD
Enalapril—ACE—adipose tissue—polycystic ovary syndrome	0.00165	0.0261	CbGeAlD
Enalapril—Hypoglycaemia—Metformin—polycystic ovary syndrome	0.00163	0.0287	CcSEcCtD
Enalapril—Pain in extremity—Metformin—polycystic ovary syndrome	0.00159	0.028	CcSEcCtD
Enalapril—Captopril—ACE—polycystic ovary syndrome	0.0015	0.129	CrCbGaD
Enalapril—ACE—adrenal gland—polycystic ovary syndrome	0.00148	0.0234	CbGeAlD
Enalapril—Cramp muscle—Metformin—polycystic ovary syndrome	0.00144	0.0252	CcSEcCtD
Enalapril—Nasopharyngitis—Metformin—polycystic ovary syndrome	0.00143	0.025	CcSEcCtD
Enalapril—ACE—female gonad—polycystic ovary syndrome	0.00138	0.0218	CbGeAlD
Enalapril—Influenza—Metformin—polycystic ovary syndrome	0.00138	0.0242	CcSEcCtD
Enalapril—Pancreatitis—Metformin—polycystic ovary syndrome	0.00135	0.0237	CcSEcCtD
Enalapril—SLCO1A2—endocrine gland—polycystic ovary syndrome	0.00135	0.0213	CbGeAlD
Enalapril—Sweating increased—Metformin—polycystic ovary syndrome	0.00134	0.0236	CcSEcCtD
Enalapril—Angina pectoris—Metformin—polycystic ovary syndrome	0.00134	0.0236	CcSEcCtD
Enalapril—Neutropenia—Metformin—polycystic ovary syndrome	0.00129	0.0226	CcSEcCtD
Enalapril—ACE—endocrine gland—polycystic ovary syndrome	0.00128	0.0203	CbGeAlD
Enalapril—Upper respiratory tract infection—Metformin—polycystic ovary syndrome	0.00128	0.0225	CcSEcCtD
Enalapril—Neuropathy peripheral—Metformin—polycystic ovary syndrome	0.0012	0.0212	CcSEcCtD
Enalapril—Fosinopril—ACE—polycystic ovary syndrome	0.00116	0.0998	CrCbGaD
Enalapril—Bradycardia—Metformin—polycystic ovary syndrome	0.00112	0.0197	CcSEcCtD
Enalapril—Hepatitis—Metformin—polycystic ovary syndrome	0.0011	0.0194	CcSEcCtD
Enalapril—Flushing—Metformin—polycystic ovary syndrome	0.00102	0.018	CcSEcCtD
Enalapril—Erythema—Metformin—polycystic ovary syndrome	0.00096	0.0169	CcSEcCtD
Enalapril—Perindopril—ACE—polycystic ovary syndrome	0.000946	0.0813	CrCbGaD
Enalapril—Flatulence—Metformin—polycystic ovary syndrome	0.000946	0.0166	CcSEcCtD
Enalapril—Dysgeusia—Metformin—polycystic ovary syndrome	0.00094	0.0165	CcSEcCtD
Enalapril—Spirapril—ACE—polycystic ovary syndrome	0.000936	0.0804	CrCbGaD
Enalapril—Muscle spasms—Metformin—polycystic ovary syndrome	0.000923	0.0162	CcSEcCtD
Enalapril—Vision blurred—Metformin—polycystic ovary syndrome	0.000905	0.0159	CcSEcCtD
Enalapril—Tremor—Metformin—polycystic ovary syndrome	0.000899	0.0158	CcSEcCtD
Enalapril—Moexipril—ACE—polycystic ovary syndrome	0.000897	0.0771	CrCbGaD
Enalapril—Benazepril—MTHFR—polycystic ovary syndrome	0.00089	0.0765	CrCbGaD
Enalapril—ABCB1—embryo—polycystic ovary syndrome	0.00088	0.0139	CbGeAlD
Enalapril—Syncope—Metformin—polycystic ovary syndrome	0.000861	0.0151	CcSEcCtD
Enalapril—Palpitations—Metformin—polycystic ovary syndrome	0.000848	0.0149	CcSEcCtD
Enalapril—Loss of consciousness—Metformin—polycystic ovary syndrome	0.000844	0.0148	CcSEcCtD
Enalapril—Quinapril—ACE—polycystic ovary syndrome	0.000834	0.0717	CrCbGaD
Enalapril—Lisinopril—ACE—polycystic ovary syndrome	0.000834	0.0717	CrCbGaD
Enalapril—Cilazapril—ACE—polycystic ovary syndrome	0.000834	0.0717	CrCbGaD
Enalapril—Myalgia—Metformin—polycystic ovary syndrome	0.000817	0.0144	CcSEcCtD
Enalapril—Chest pain—Metformin—polycystic ovary syndrome	0.000817	0.0144	CcSEcCtD
Enalapril—Trandolapril—ACE—polycystic ovary syndrome	0.000808	0.0694	CrCbGaD
Enalapril—Ramipril—ACE—polycystic ovary syndrome	0.000808	0.0694	CrCbGaD
Enalapril—Discomfort—Metformin—polycystic ovary syndrome	0.000807	0.0142	CcSEcCtD
Enalapril—ACE—Peptide hormone metabolism—LHB—polycystic ovary syndrome	0.000796	0.0217	CbGpPWpGaD
Enalapril—Oedema—Metformin—polycystic ovary syndrome	0.000783	0.0138	CcSEcCtD
Enalapril—Shock—Metformin—polycystic ovary syndrome	0.000771	0.0135	CcSEcCtD
Enalapril—Thrombocytopenia—Metformin—polycystic ovary syndrome	0.000767	0.0135	CcSEcCtD
Enalapril—Hyperhidrosis—Metformin—polycystic ovary syndrome	0.000757	0.0133	CcSEcCtD
Enalapril—Anorexia—Metformin—polycystic ovary syndrome	0.000747	0.0131	CcSEcCtD
Enalapril—Hypotension—Metformin—polycystic ovary syndrome	0.000732	0.0129	CcSEcCtD
Enalapril—Benazepril—ACE—polycystic ovary syndrome	0.000725	0.0624	CrCbGaD
Enalapril—ABCB1—adrenal cortex—polycystic ovary syndrome	0.000721	0.0114	CbGeAlD
Enalapril—Musculoskeletal discomfort—Metformin—polycystic ovary syndrome	0.000714	0.0125	CcSEcCtD
Enalapril—Paraesthesia—Metformin—polycystic ovary syndrome	0.000703	0.0124	CcSEcCtD
Enalapril—Dyspnoea—Metformin—polycystic ovary syndrome	0.000698	0.0123	CcSEcCtD
Enalapril—Somnolence—Metformin—polycystic ovary syndrome	0.000696	0.0122	CcSEcCtD
Enalapril—Dyspepsia—Metformin—polycystic ovary syndrome	0.00069	0.0121	CcSEcCtD
Enalapril—SLCO1A2—Bile acid and bile salt metabolism—AKR1C1—polycystic ovary syndrome	0.000685	0.0187	CbGpPWpGaD
Enalapril—Decreased appetite—Metformin—polycystic ovary syndrome	0.000681	0.012	CcSEcCtD
Enalapril—Fatigue—Metformin—polycystic ovary syndrome	0.000675	0.0119	CcSEcCtD
Enalapril—Constipation—Metformin—polycystic ovary syndrome	0.00067	0.0118	CcSEcCtD
Enalapril—Feeling abnormal—Metformin—polycystic ovary syndrome	0.000646	0.0113	CcSEcCtD
Enalapril—ABCB1—endometrium—polycystic ovary syndrome	0.000644	0.0102	CbGeAlD
Enalapril—Gastrointestinal pain—Metformin—polycystic ovary syndrome	0.000641	0.0113	CcSEcCtD
Enalapril—CYP3A4—endocrine gland—polycystic ovary syndrome	0.000638	0.0101	CbGeAlD
Enalapril—Urticaria—Metformin—polycystic ovary syndrome	0.000622	0.0109	CcSEcCtD
Enalapril—Abdominal pain—Metformin—polycystic ovary syndrome	0.000619	0.0109	CcSEcCtD
Enalapril—ABCB1—uterus—polycystic ovary syndrome	0.000594	0.00938	CbGeAlD
Enalapril—ABCB1—pituitary gland—polycystic ovary syndrome	0.000583	0.00922	CbGeAlD
Enalapril—ABCB1—adipose tissue—polycystic ovary syndrome	0.000581	0.00918	CbGeAlD
Enalapril—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—BCL11A—polycystic ovary syndrome	0.00057	0.0155	CbGpPWpGaD
Enalapril—Asthenia—Metformin—polycystic ovary syndrome	0.000562	0.00988	CcSEcCtD
Enalapril—Pruritus—Metformin—polycystic ovary syndrome	0.000554	0.00974	CcSEcCtD
Enalapril—CYP3A4—Benzo(a)pyrene metabolism—AKR1C1—polycystic ovary syndrome	0.000548	0.0149	CbGpPWpGaD
Enalapril—Diarrhoea—Metformin—polycystic ovary syndrome	0.000536	0.00942	CcSEcCtD
Enalapril—SLCO1A2—Bile acid and bile salt metabolism—AKR1C3—polycystic ovary syndrome	0.000528	0.0144	CbGpPWpGaD
Enalapril—ACE—Peptide hormone metabolism—GHRL—polycystic ovary syndrome	0.000526	0.0143	CbGpPWpGaD
Enalapril—ABCB1—adrenal gland—polycystic ovary syndrome	0.000521	0.00823	CbGeAlD
Enalapril—Dizziness—Metformin—polycystic ovary syndrome	0.000518	0.0091	CcSEcCtD
Enalapril—Vomiting—Metformin—polycystic ovary syndrome	0.000498	0.00875	CcSEcCtD
Enalapril—Rash—Metformin—polycystic ovary syndrome	0.000494	0.00868	CcSEcCtD
Enalapril—Dermatitis—Metformin—polycystic ovary syndrome	0.000493	0.00867	CcSEcCtD
Enalapril—ABCB1—Drug Induction of Bile Acid Pathway—SULT2A1—polycystic ovary syndrome	0.000492	0.0134	CbGpPWpGaD
Enalapril—Headache—Metformin—polycystic ovary syndrome	0.000491	0.00863	CcSEcCtD
Enalapril—ACE—Peptide hormone metabolism—TCF7L2—polycystic ovary syndrome	0.000489	0.0133	CbGpPWpGaD
Enalapril—ABCB1—female gonad—polycystic ovary syndrome	0.000486	0.00768	CbGeAlD
Enalapril—ABCB1—vagina—polycystic ovary syndrome	0.000483	0.00763	CbGeAlD
Enalapril—Nausea—Metformin—polycystic ovary syndrome	0.000465	0.00818	CcSEcCtD
Enalapril—Nateglinide—PPARG—polycystic ovary syndrome	0.000455	0.0391	CrCbGaD
Enalapril—ABCB1—endocrine gland—polycystic ovary syndrome	0.000452	0.00714	CbGeAlD
Enalapril—SLC22A7—Fluoropyrimidine Activity—MTHFR—polycystic ovary syndrome	0.000444	0.0121	CbGpPWpGaD
Enalapril—CYP3A4—Benzo(a)pyrene metabolism—AKR1C3—polycystic ovary syndrome	0.000422	0.0115	CbGpPWpGaD
Enalapril—ACE—Metabolism of proteins—CGB5—polycystic ovary syndrome	0.000354	0.00964	CbGpPWpGaD
Enalapril—ACE—Metabolism of proteins—MANEA—polycystic ovary syndrome	0.000324	0.00882	CbGpPWpGaD
Enalapril—ACE—Peptide hormone metabolism—LEP—polycystic ovary syndrome	0.000316	0.00862	CbGpPWpGaD
Enalapril—CYP3A4—Drug Induction of Bile Acid Pathway—SULT2A1—polycystic ovary syndrome	0.000303	0.00826	CbGpPWpGaD
Enalapril—ABCB1—Constitutive Androstane Receptor Pathway—SULT2A1—polycystic ovary syndrome	0.000297	0.00808	CbGpPWpGaD
Enalapril—CYP3A4—Farnesoid X Receptor  Pathway—SULT2A1—polycystic ovary syndrome	0.000277	0.00756	CbGpPWpGaD
Enalapril—ACE—Peptide hormone metabolism—POMC—polycystic ovary syndrome	0.000272	0.0074	CbGpPWpGaD
Enalapril—ACE—Peptide hormone metabolism—INS—polycystic ovary syndrome	0.00027	0.00736	CbGpPWpGaD
Enalapril—ACE—Metabolism of proteins—CPB2—polycystic ovary syndrome	0.000268	0.00731	CbGpPWpGaD
Enalapril—ACE—Metabolism of proteins—ADAMTS7—polycystic ovary syndrome	0.000268	0.00731	CbGpPWpGaD
Enalapril—SLC22A7—Transmembrane transport of small molecules—ABCB6—polycystic ovary syndrome	0.000268	0.00729	CbGpPWpGaD
Enalapril—SLC22A7—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A4—polycystic ovary syndrome	0.000265	0.00722	CbGpPWpGaD
Enalapril—CYP3A4—Benzo(a)pyrene metabolism—CYP1A1—polycystic ovary syndrome	0.000265	0.00722	CbGpPWpGaD
Enalapril—ACE—Peptide hormone metabolism—IGF1—polycystic ovary syndrome	0.000261	0.00712	CbGpPWpGaD
Enalapril—CYP3A4—Tamoxifen metabolism—SULT2A1—polycystic ovary syndrome	0.000256	0.00698	CbGpPWpGaD
Enalapril—SLC15A1—Transmembrane transport of small molecules—ABCB6—polycystic ovary syndrome	0.000253	0.00689	CbGpPWpGaD
Enalapril—SLC22A8—Transmembrane transport of small molecules—ABCB6—polycystic ovary syndrome	0.000225	0.00613	CbGpPWpGaD
Enalapril—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A4—polycystic ovary syndrome	0.000223	0.00607	CbGpPWpGaD
Enalapril—ACE—Metabolism of proteins—INHBB—polycystic ovary syndrome	0.000203	0.00554	CbGpPWpGaD
Enalapril—SLCO1A2—Transmembrane transport of small molecules—ABCB6—polycystic ovary syndrome	0.0002	0.00544	CbGpPWpGaD
Enalapril—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—GAB1—polycystic ovary syndrome	0.000194	0.00529	CbGpPWpGaD
Enalapril—SLC22A7—Transmembrane transport of small molecules—TRPV6—polycystic ovary syndrome	0.000191	0.0052	CbGpPWpGaD
Enalapril—SLC22A6—Transmembrane transport of small molecules—ABCB6—polycystic ovary syndrome	0.000188	0.00512	CbGpPWpGaD
Enalapril—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A4—polycystic ovary syndrome	0.000186	0.00507	CbGpPWpGaD
Enalapril—CYP3A4—Constitutive Androstane Receptor Pathway—SULT2A1—polycystic ovary syndrome	0.000183	0.00498	CbGpPWpGaD
Enalapril—ACE—Metabolism of proteins—RPL37A—polycystic ovary syndrome	0.000182	0.00497	CbGpPWpGaD
Enalapril—SLC15A1—Transmembrane transport of small molecules—TRPV6—polycystic ovary syndrome	0.00018	0.00491	CbGpPWpGaD
Enalapril—SLC22A7—Transmembrane transport of small molecules—SCNN1A—polycystic ovary syndrome	0.000173	0.0047	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism of lipids and lipoproteins—LPCAT2—polycystic ovary syndrome	0.000171	0.00467	CbGpPWpGaD
Enalapril—ABCB1—HIF-1-alpha transcription factor network—IGFBP1—polycystic ovary syndrome	0.000171	0.00465	CbGpPWpGaD
Enalapril—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—polycystic ovary syndrome	0.000167	0.00456	CbGpPWpGaD
Enalapril—SLC15A1—Transmembrane transport of small molecules—SCNN1A—polycystic ovary syndrome	0.000163	0.00444	CbGpPWpGaD
Enalapril—SLC22A8—Transmembrane transport of small molecules—TRPV6—polycystic ovary syndrome	0.00016	0.00437	CbGpPWpGaD
Enalapril—CYP3A4—Estrogen metabolism—CYP1A1—polycystic ovary syndrome	0.000152	0.00415	CbGpPWpGaD
Enalapril—ACE—Metabolism of proteins—LHB—polycystic ovary syndrome	0.00015	0.0041	CbGpPWpGaD
Enalapril—ABCB1—Allograft Rejection—FOXP3—polycystic ovary syndrome	0.000149	0.00406	CbGpPWpGaD
Enalapril—SLC22A8—Transmembrane transport of small molecules—SCNN1A—polycystic ovary syndrome	0.000145	0.00395	CbGpPWpGaD
Enalapril—SLCO1A2—Transmembrane transport of small molecules—TRPV6—polycystic ovary syndrome	0.000142	0.00388	CbGpPWpGaD
Enalapril—CYP3A4—Xenobiotics—CYP1A1—polycystic ovary syndrome	0.00014	0.00381	CbGpPWpGaD
Enalapril—ABCB1—HIF-1-alpha transcription factor network—TFRC—polycystic ovary syndrome	0.000136	0.00369	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism of lipids and lipoproteins—TEAD2—polycystic ovary syndrome	0.000135	0.00369	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism of lipids and lipoproteins—AKR1C2—polycystic ovary syndrome	0.000135	0.00369	CbGpPWpGaD
Enalapril—CYP3A4—Tamoxifen metabolism—CYP1A1—polycystic ovary syndrome	0.000135	0.00366	CbGpPWpGaD
Enalapril—ACE—Metabolism of proteins—IGFBP1—polycystic ovary syndrome	0.000134	0.00366	CbGpPWpGaD
Enalapril—SLC22A6—Transmembrane transport of small molecules—TRPV6—polycystic ovary syndrome	0.000134	0.00365	CbGpPWpGaD
Enalapril—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—polycystic ovary syndrome	0.000129	0.00352	CbGpPWpGaD
Enalapril—SLCO1A2—Transmembrane transport of small molecules—SCNN1A—polycystic ovary syndrome	0.000129	0.00351	CbGpPWpGaD
Enalapril—SLC22A6—Transmembrane transport of small molecules—SCNN1A—polycystic ovary syndrome	0.000121	0.0033	CbGpPWpGaD
Enalapril—SLC22A7—SLC-mediated transmembrane transport—SLC2A4—polycystic ovary syndrome	0.00012	0.00328	CbGpPWpGaD
Enalapril—SLC15A1—SLC-mediated transmembrane transport—SLC2A4—polycystic ovary syndrome	0.000114	0.0031	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism of lipids and lipoproteins—PNPLA2—polycystic ovary syndrome	0.000113	0.00309	CbGpPWpGaD
Enalapril—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—polycystic ovary syndrome	0.000112	0.00306	CbGpPWpGaD
Enalapril—ACE—Metabolism of proteins—LMNA—polycystic ovary syndrome	0.000111	0.00303	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism of lipids and lipoproteins—SRD5A1—polycystic ovary syndrome	0.000108	0.00293	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism of lipids and lipoproteins—STAR—polycystic ovary syndrome	0.000103	0.0028	CbGpPWpGaD
Enalapril—SLC22A8—SLC-mediated transmembrane transport—SLC2A4—polycystic ovary syndrome	0.000101	0.00276	CbGpPWpGaD
Enalapril—ACE—Metabolism of proteins—GHRL—polycystic ovary syndrome	9.92e-05	0.0027	CbGpPWpGaD
Enalapril—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP11A1—polycystic ovary syndrome	9.79e-05	0.00267	CbGpPWpGaD
Enalapril—CYP3A4—Oxidation by Cytochrome P450—CYP11A1—polycystic ovary syndrome	9.66e-05	0.00263	CbGpPWpGaD
Enalapril—ACE—Metabolism of proteins—TCF7L2—polycystic ovary syndrome	9.23e-05	0.00252	CbGpPWpGaD
Enalapril—CYP3A4—Metapathway biotransformation—AKR1C2—polycystic ovary syndrome	9.17e-05	0.0025	CbGpPWpGaD
Enalapril—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP17A1—polycystic ovary syndrome	9.1e-05	0.00248	CbGpPWpGaD
Enalapril—SLCO1A2—SLC-mediated transmembrane transport—SLC2A4—polycystic ovary syndrome	8.99e-05	0.00245	CbGpPWpGaD
Enalapril—CYP3A4—Oxidation by Cytochrome P450—CYP17A1—polycystic ovary syndrome	8.99e-05	0.00245	CbGpPWpGaD
Enalapril—CYP3A4—Tryptophan metabolism—CYP19A1—polycystic ovary syndrome	8.91e-05	0.00243	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism of lipids and lipoproteins—HSD3B1—polycystic ovary syndrome	8.73e-05	0.00238	CbGpPWpGaD
Enalapril—ABCB1—Transmembrane transport of small molecules—ABCB6—polycystic ovary syndrome	8.55e-05	0.00233	CbGpPWpGaD
Enalapril—SLC22A6—SLC-mediated transmembrane transport—SLC2A4—polycystic ovary syndrome	8.45e-05	0.0023	CbGpPWpGaD
Enalapril—ABCB1—Integrated Pancreatic Cancer Pathway—FST—polycystic ovary syndrome	8.36e-05	0.00228	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—NMNAT3—polycystic ovary syndrome	8.34e-05	0.00227	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism of lipids and lipoproteins—LHB—polycystic ovary syndrome	7.96e-05	0.00217	CbGpPWpGaD
Enalapril—CYP3A4—Phase 1 - Functionalization of compounds—CYP11A1—polycystic ovary syndrome	7.94e-05	0.00216	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism of lipids and lipoproteins—HSD3B2—polycystic ovary syndrome	7.78e-05	0.00212	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—SUOX—polycystic ovary syndrome	7.63e-05	0.00208	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—LPCAT2—polycystic ovary syndrome	7.63e-05	0.00208	CbGpPWpGaD
Enalapril—ABCB1—HIF-1-alpha transcription factor network—LEP—polycystic ovary syndrome	7.58e-05	0.00207	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism of lipids and lipoproteins—AKR1C1—polycystic ovary syndrome	7.53e-05	0.00205	CbGpPWpGaD
Enalapril—CYP3A4—Phase 1 - Functionalization of compounds—CYP17A1—polycystic ovary syndrome	7.38e-05	0.00201	CbGpPWpGaD
Enalapril—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—polycystic ovary syndrome	7.21e-05	0.00196	CbGpPWpGaD
Enalapril—SLC22A7—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	7.2e-05	0.00196	CbGpPWpGaD
Enalapril—CYP3A4—Tryptophan metabolism—CYP1A1—polycystic ovary syndrome	7.18e-05	0.00196	CbGpPWpGaD
Enalapril—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—polycystic ovary syndrome	7.11e-05	0.00194	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—ISYNA1—polycystic ovary syndrome	7.09e-05	0.00193	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism of lipids and lipoproteins—SULT2A1—polycystic ovary syndrome	6.93e-05	0.00189	CbGpPWpGaD
Enalapril—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—polycystic ovary syndrome	6.92e-05	0.00188	CbGpPWpGaD
Enalapril—SLC15A1—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	6.8e-05	0.00185	CbGpPWpGaD
Enalapril—SLC22A7—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	6.69e-05	0.00182	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism of lipids and lipoproteins—YAP1—polycystic ovary syndrome	6.47e-05	0.00176	CbGpPWpGaD
Enalapril—SLC15A1—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	6.32e-05	0.00172	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism of lipids and lipoproteins—CYP11A1—polycystic ovary syndrome	6.14e-05	0.00167	CbGpPWpGaD
Enalapril—SLC22A7—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	6.12e-05	0.00167	CbGpPWpGaD
Enalapril—ABCB1—Transmembrane transport of small molecules—TRPV6—polycystic ovary syndrome	6.09e-05	0.00166	CbGpPWpGaD
Enalapril—SLC22A8—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	6.05e-05	0.00165	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—AKR1C2—polycystic ovary syndrome	6.03e-05	0.00164	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—TEAD2—polycystic ovary syndrome	6.03e-05	0.00164	CbGpPWpGaD
Enalapril—ACE—Metabolism of proteins—LEP—polycystic ovary syndrome	5.97e-05	0.00163	CbGpPWpGaD
Enalapril—ABCB1—HIF-1-alpha transcription factor network—SERPINE1—polycystic ovary syndrome	5.95e-05	0.00162	CbGpPWpGaD
Enalapril—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—polycystic ovary syndrome	5.84e-05	0.00159	CbGpPWpGaD
Enalapril—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—polycystic ovary syndrome	5.81e-05	0.00158	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	5.8e-05	0.00158	CbGpPWpGaD
Enalapril—ABCB1—Integrated Pancreatic Cancer Pathway—TOP2A—polycystic ovary syndrome	5.79e-05	0.00158	CbGpPWpGaD
Enalapril—SLC15A1—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	5.78e-05	0.00158	CbGpPWpGaD
Enalapril—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—polycystic ovary syndrome	5.73e-05	0.00156	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	5.71e-05	0.00156	CbGpPWpGaD
Enalapril—SLC22A8—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	5.63e-05	0.00153	CbGpPWpGaD
Enalapril—ABCB1—Transmembrane transport of small molecules—SCNN1A—polycystic ovary syndrome	5.51e-05	0.0015	CbGpPWpGaD
Enalapril—SLCO1A2—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	5.37e-05	0.00146	CbGpPWpGaD
Enalapril—SLC22A8—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	5.15e-05	0.0014	CbGpPWpGaD
Enalapril—SLC22A7—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	5.14e-05	0.0014	CbGpPWpGaD
Enalapril—ACE—Metabolism of proteins—POMC—polycystic ovary syndrome	5.13e-05	0.0014	CbGpPWpGaD
Enalapril—CYP3A4—Metapathway biotransformation—AKR1C1—polycystic ovary syndrome	5.1e-05	0.00139	CbGpPWpGaD
Enalapril—ACE—Metabolism of proteins—INS—polycystic ovary syndrome	5.1e-05	0.00139	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—PNPLA2—polycystic ovary syndrome	5.05e-05	0.00138	CbGpPWpGaD
Enalapril—SLC22A6—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	5.05e-05	0.00138	CbGpPWpGaD
Enalapril—SLCO1A2—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	5e-05	0.00136	CbGpPWpGaD
Enalapril—ACE—Metabolism of proteins—IGF1—polycystic ovary syndrome	4.93e-05	0.00134	CbGpPWpGaD
Enalapril—SLC15A1—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	4.85e-05	0.00132	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—SRD5A1—polycystic ovary syndrome	4.79e-05	0.00131	CbGpPWpGaD
Enalapril—CYP3A4—Biological oxidations—SULT2A1—polycystic ovary syndrome	4.76e-05	0.0013	CbGpPWpGaD
Enalapril—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—polycystic ovary syndrome	4.71e-05	0.00128	CbGpPWpGaD
Enalapril—CYP3A4—Metapathway biotransformation—SULT2A1—polycystic ovary syndrome	4.7e-05	0.00128	CbGpPWpGaD
Enalapril—SLC22A6—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	4.7e-05	0.00128	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—STAR—polycystic ovary syndrome	4.57e-05	0.00125	CbGpPWpGaD
Enalapril—SLCO1A2—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	4.57e-05	0.00124	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	4.52e-05	0.00123	CbGpPWpGaD
Enalapril—ABCB1—Integrated Pancreatic Cancer Pathway—AR—polycystic ovary syndrome	4.51e-05	0.00123	CbGpPWpGaD
Enalapril—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—polycystic ovary syndrome	4.33e-05	0.00118	CbGpPWpGaD
Enalapril—SLC22A8—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	4.32e-05	0.00118	CbGpPWpGaD
Enalapril—SLC22A6—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	4.29e-05	0.00117	CbGpPWpGaD
Enalapril—CYP3A4—Biological oxidations—CYP11A1—polycystic ovary syndrome	4.22e-05	0.00115	CbGpPWpGaD
Enalapril—CYP3A4—Metapathway biotransformation—CYP11A1—polycystic ovary syndrome	4.16e-05	0.00113	CbGpPWpGaD
Enalapril—ABCB1—HIF-1-alpha transcription factor network—VEGFA—polycystic ovary syndrome	4.09e-05	0.00111	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—HMMR—polycystic ovary syndrome	4.07e-05	0.00111	CbGpPWpGaD
Enalapril—CYP3A4—Metapathway biotransformation—AKR1C3—polycystic ovary syndrome	3.93e-05	0.00107	CbGpPWpGaD
Enalapril—CYP3A4—Biological oxidations—CYP17A1—polycystic ovary syndrome	3.92e-05	0.00107	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—HSD3B1—polycystic ovary syndrome	3.89e-05	0.00106	CbGpPWpGaD
Enalapril—CYP3A4—Metapathway biotransformation—CYP17A1—polycystic ovary syndrome	3.87e-05	0.00105	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	3.84e-05	0.00105	CbGpPWpGaD
Enalapril—ABCB1—Integrated Pancreatic Cancer Pathway—BAX—polycystic ovary syndrome	3.84e-05	0.00105	CbGpPWpGaD
Enalapril—SLCO1A2—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	3.83e-05	0.00104	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	3.64e-05	0.000992	CbGpPWpGaD
Enalapril—SLC22A6—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	3.6e-05	0.000982	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—NMNAT3—polycystic ovary syndrome	3.57e-05	0.000973	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—LHB—polycystic ovary syndrome	3.54e-05	0.000965	CbGpPWpGaD
Enalapril—ABCB1—Allograft Rejection—VEGFA—polycystic ovary syndrome	3.54e-05	0.000965	CbGpPWpGaD
Enalapril—CYP3A4—Phase 1 - Functionalization of compounds—POMC—polycystic ovary syndrome	3.51e-05	0.000956	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—HSD3B2—polycystic ovary syndrome	3.46e-05	0.000944	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—AKR1C1—polycystic ovary syndrome	3.35e-05	0.000914	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—LPCAT2—polycystic ovary syndrome	3.27e-05	0.00089	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—SUOX—polycystic ovary syndrome	3.27e-05	0.00089	CbGpPWpGaD
Enalapril—CYP3A4—Biological oxidations—CYP19A1—polycystic ovary syndrome	3.1e-05	0.000845	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—SULT2A1—polycystic ovary syndrome	3.09e-05	0.000841	CbGpPWpGaD
Enalapril—CYP3A4—Metapathway biotransformation—CYP19A1—polycystic ovary syndrome	3.06e-05	0.000834	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—ISYNA1—polycystic ovary syndrome	3.04e-05	0.000827	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—RRM2—polycystic ovary syndrome	2.99e-05	0.000815	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—YAP1—polycystic ovary syndrome	2.88e-05	0.000785	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—NAMPT—polycystic ovary syndrome	2.77e-05	0.000754	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	2.75e-05	0.00075	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—CYP11A1—polycystic ovary syndrome	2.73e-05	0.000745	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	2.71e-05	0.00074	CbGpPWpGaD
Enalapril—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—polycystic ovary syndrome	2.68e-05	0.000729	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—AKR1C3—polycystic ovary syndrome	2.58e-05	0.000704	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—TEAD2—polycystic ovary syndrome	2.58e-05	0.000703	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—AKR1C2—polycystic ovary syndrome	2.58e-05	0.000703	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—CYP17A1—polycystic ovary syndrome	2.54e-05	0.000693	CbGpPWpGaD
Enalapril—CYP3A4—Biological oxidations—CYP1A1—polycystic ovary syndrome	2.5e-05	0.000681	CbGpPWpGaD
Enalapril—CYP3A4—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	2.47e-05	0.000672	CbGpPWpGaD
Enalapril—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—polycystic ovary syndrome	2.34e-05	0.000637	CbGpPWpGaD
Enalapril—ABCB1—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	2.3e-05	0.000627	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—NMNAT3—polycystic ovary syndrome	2.2e-05	0.000599	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—TH—polycystic ovary syndrome	2.2e-05	0.000599	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—PNPLA2—polycystic ovary syndrome	2.16e-05	0.000589	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—SLC2A4—polycystic ovary syndrome	2.14e-05	0.000583	CbGpPWpGaD
Enalapril—ABCB1—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	2.14e-05	0.000583	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—SRD5A1—polycystic ovary syndrome	2.05e-05	0.000559	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—LPCAT2—polycystic ovary syndrome	2.01e-05	0.000548	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—SUOX—polycystic ovary syndrome	2.01e-05	0.000548	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—CYP19A1—polycystic ovary syndrome	2.01e-05	0.000548	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—STAR—polycystic ovary syndrome	1.96e-05	0.000533	CbGpPWpGaD
Enalapril—ABCB1—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	1.96e-05	0.000533	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—ISYNA1—polycystic ovary syndrome	1.87e-05	0.00051	CbGpPWpGaD
Enalapril—CYP3A4—Biological oxidations—POMC—polycystic ovary syndrome	1.86e-05	0.000508	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—GNAS—polycystic ovary syndrome	1.8e-05	0.000489	CbGpPWpGaD
Enalapril—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—polycystic ovary syndrome	1.75e-05	0.000476	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—HMMR—polycystic ovary syndrome	1.74e-05	0.000475	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—NCOR1—polycystic ovary syndrome	1.71e-05	0.000466	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—HSD3B1—polycystic ovary syndrome	1.66e-05	0.000453	CbGpPWpGaD
Enalapril—ABCB1—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	1.64e-05	0.000447	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—CYP1A1—polycystic ovary syndrome	1.62e-05	0.000442	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—AKR1C2—polycystic ovary syndrome	1.59e-05	0.000433	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—TEAD2—polycystic ovary syndrome	1.59e-05	0.000433	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—LHB—polycystic ovary syndrome	1.52e-05	0.000413	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—MTHFR—polycystic ovary syndrome	1.51e-05	0.000412	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—HSD3B2—polycystic ovary syndrome	1.48e-05	0.000404	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—AKR1C1—polycystic ovary syndrome	1.44e-05	0.000391	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—PNPLA2—polycystic ovary syndrome	1.33e-05	0.000363	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—SULT2A1—polycystic ovary syndrome	1.32e-05	0.00036	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—RRM2—polycystic ovary syndrome	1.28e-05	0.000349	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—SRD5A1—polycystic ovary syndrome	1.26e-05	0.000344	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—YAP1—polycystic ovary syndrome	1.23e-05	0.000336	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—PPARG—polycystic ovary syndrome	1.23e-05	0.000334	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—POMC—polycystic ovary syndrome	1.21e-05	0.000329	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—STAR—polycystic ovary syndrome	1.21e-05	0.000328	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—INS—polycystic ovary syndrome	1.2e-05	0.000328	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—NAMPT—polycystic ovary syndrome	1.19e-05	0.000323	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—CYP11A1—polycystic ovary syndrome	1.17e-05	0.000319	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—AKR1C3—polycystic ovary syndrome	1.11e-05	0.000301	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—CYP17A1—polycystic ovary syndrome	1.09e-05	0.000297	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—HMMR—polycystic ovary syndrome	1.07e-05	0.000293	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—HSD3B1—polycystic ovary syndrome	1.02e-05	0.000279	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—TH—polycystic ovary syndrome	9.42e-06	0.000257	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—LHB—polycystic ovary syndrome	9.35e-06	0.000255	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—SLC2A4—polycystic ovary syndrome	9.16e-06	0.00025	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—HSD3B2—polycystic ovary syndrome	9.14e-06	0.000249	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—AKR1C1—polycystic ovary syndrome	8.85e-06	0.000241	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—CYP19A1—polycystic ovary syndrome	8.61e-06	0.000235	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—SULT2A1—polycystic ovary syndrome	8.14e-06	0.000222	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—RRM2—polycystic ovary syndrome	7.89e-06	0.000215	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—GNAS—polycystic ovary syndrome	7.69e-06	0.000209	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—YAP1—polycystic ovary syndrome	7.6e-06	0.000207	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—NCOR1—polycystic ovary syndrome	7.32e-06	0.0002	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—NAMPT—polycystic ovary syndrome	7.3e-06	0.000199	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—CYP11A1—polycystic ovary syndrome	7.21e-06	0.000197	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—CYP1A1—polycystic ovary syndrome	6.94e-06	0.000189	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—AKR1C3—polycystic ovary syndrome	6.81e-06	0.000186	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—CYP17A1—polycystic ovary syndrome	6.7e-06	0.000183	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—MTHFR—polycystic ovary syndrome	6.47e-06	0.000176	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—TH—polycystic ovary syndrome	5.8e-06	0.000158	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—SLC2A4—polycystic ovary syndrome	5.64e-06	0.000154	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—CYP19A1—polycystic ovary syndrome	5.31e-06	0.000145	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—PPARG—polycystic ovary syndrome	5.25e-06	0.000143	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—POMC—polycystic ovary syndrome	5.18e-06	0.000141	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—INS—polycystic ovary syndrome	5.15e-06	0.00014	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—GNAS—polycystic ovary syndrome	4.74e-06	0.000129	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—NCOR1—polycystic ovary syndrome	4.51e-06	0.000123	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—CYP1A1—polycystic ovary syndrome	4.28e-06	0.000117	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—MTHFR—polycystic ovary syndrome	3.99e-06	0.000109	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—PPARG—polycystic ovary syndrome	3.23e-06	8.81e-05	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—POMC—polycystic ovary syndrome	3.19e-06	8.69e-05	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—INS—polycystic ovary syndrome	3.17e-06	8.64e-05	CbGpPWpGaD
